Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 38% ± 18% | |
microglial cell | 9 studies | 26% ± 10% | |
type I pneumocyte | 7 studies | 25% ± 6% | |
club cell | 7 studies | 25% ± 10% | |
respiratory goblet cell | 6 studies | 35% ± 16% | |
basal cell | 5 studies | 23% ± 5% | |
secretory cell | 3 studies | 29% ± 8% | |
epithelial cell | 3 studies | 34% ± 8% | |
Mueller cell | 3 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 23% ± 4% | |
glutamatergic neuron | 3 studies | 30% ± 3% | |
plasma cell | 3 studies | 30% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1809.49 | 2613 / 2642 | 98% | 55.68 | 692 / 705 |
prostate | 98% | 3265.36 | 241 / 245 | 96% | 44.00 | 482 / 502 |
lung | 100% | 1850.37 | 577 / 578 | 74% | 13.53 | 849 / 1155 |
thymus | 94% | 632.65 | 612 / 653 | 63% | 7.58 | 381 / 605 |
pancreas | 95% | 528.91 | 311 / 328 | 53% | 4.84 | 95 / 178 |
kidney | 98% | 1016.44 | 87 / 89 | 27% | 4.19 | 246 / 901 |
ovary | 51% | 155.94 | 91 / 180 | 71% | 10.49 | 304 / 430 |
uterus | 59% | 254.99 | 100 / 170 | 58% | 9.65 | 265 / 459 |
esophagus | 59% | 338.19 | 852 / 1445 | 48% | 4.41 | 87 / 183 |
bladder | 67% | 409.90 | 14 / 21 | 38% | 5.14 | 193 / 504 |
spleen | 100% | 1639.15 | 241 / 241 | 0% | 0 | 0 / 0 |
breast | 62% | 284.59 | 286 / 459 | 36% | 3.79 | 399 / 1118 |
intestine | 70% | 353.30 | 674 / 966 | 6% | 0.43 | 31 / 527 |
peripheral blood | 75% | 473.18 | 700 / 929 | 0% | 0 | 0 / 0 |
heart | 69% | 322.70 | 597 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 62% | 210.94 | 160 / 258 | 2% | 0.21 | 4 / 230 |
tonsil | 0% | 0 | 0 / 0 | 60% | 13.51 | 27 / 45 |
adipose | 57% | 196.37 | 685 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 3.73 | 15 / 29 |
blood vessel | 39% | 122.37 | 519 / 1335 | 0% | 0 | 0 / 0 |
stomach | 32% | 101.38 | 115 / 359 | 4% | 0.39 | 11 / 286 |
skin | 18% | 49.22 | 318 / 1809 | 8% | 0.89 | 39 / 472 |
liver | 18% | 54.69 | 41 / 226 | 1% | 0.23 | 5 / 406 |
muscle | 7% | 19.99 | 59 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.12 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015835 | Biological process | peptidoglycan transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0006811 | Biological process | monoatomic ion transport |
GO_1990961 | Biological process | xenobiotic detoxification by transmembrane export across the plasma membrane |
GO_0042938 | Biological process | dipeptide transport |
GO_0140207 | Biological process | tripeptide import across plasma membrane |
GO_0140367 | Biological process | antibacterial innate immune response |
GO_0042908 | Biological process | xenobiotic transport |
GO_0070293 | Biological process | renal absorption |
GO_0015833 | Biological process | peptide transport |
GO_0070424 | Biological process | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
GO_0015031 | Biological process | protein transport |
GO_0140206 | Biological process | dipeptide import across plasma membrane |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0071916 | Molecular function | dipeptide transmembrane transporter activity |
GO_0015333 | Molecular function | peptide:proton symporter activity |
GO_0042937 | Molecular function | tripeptide transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC15A2 |
Protein name | Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2) Solute carrier family 15 member 2 (Peptide transporter 2) |
Synonyms | PEPT2 |
Description | FUNCTION: Proton-coupled amino-acid transporter that transports oligopeptides of 2 to 4 amino acids with a preference for dipeptides . Transports neutral and anionic dipeptides with a proton to peptide stoichiometry of 2:1 or 3:1 (By similarity). In kidney, involved in the absorption of circulating di- and tripeptides from the glomerular filtrate . Can also transport beta-lactam antibiotics, such as the aminocephalosporin cefadroxil, and other antiviral and anticancer drugs . Transports the dipeptide-like aminopeptidase inhibitor bestatin (By similarity). Also able to transport carnosine . Involved in innate immunity by promoting the detection of microbial pathogens by NOD-like receptors (NLRs) (By similarity). Mediates transport of bacterial peptidoglycans across the plasma membrane or, in macrophages, the phagosome membrane: catalyzes the transport of certain bacterial peptidoglycans, such as muramyl dipeptide (MDP), the NOD2 ligand . . |
Accessions | ENST00000295605.6 [Q16348-2] ENST00000489711.6 [Q16348-1] Q16348 ENST00000469013.1 C9IZ38 A0PJB0 Q86UE9 |